Cargando…
Somatotroph Tumors and the Epigenetic Status of the GNAS Locus
Forty percent of somatotroph tumors harbor recurrent activating GNAS mutations, historically called the gsp oncogene. In gsp-negative somatotroph tumors, GNAS expression itself is highly variable; those with GNAS overexpression most resemble phenotypically those carrying the gsp oncogene. GNAS is mo...
Autores principales: | Romanet, Pauline, Galluso, Justine, Kamenicky, Peter, Hage, Mirella, Theodoropoulou, Marily, Roche, Catherine, Graillon, Thomas, Etchevers, Heather C., De Murat, Daniel, Mougel, Grégory, Figarella-Branger, Dominique, Dufour, Henry, Cuny, Thomas, Assié, Guillaume, Barlier, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306130/ https://www.ncbi.nlm.nih.gov/pubmed/34299200 http://dx.doi.org/10.3390/ijms22147570 |
Ejemplares similares
-
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells
por: Cuny, Thomas, et al.
Publicado: (2016) -
Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas
por: Graillon, Thomas, et al.
Publicado: (2020) -
Dose-Dependent Dual Role of PIT-1 (POU1F1) in Somatolactotroph Cell Proliferation and Apoptosis
por: Jullien, Nicolas, et al.
Publicado: (2015) -
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro
por: Graillon, Thomas, et al.
Publicado: (2017) -
Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib
por: Mondielli, Gregoire, et al.
Publicado: (2022)